ABOUT APRECIA PHARMACEUTICALS

DELIVERING BETTER PHARMACEUTICALS THROUGH INNOVATIVE PLATFORMS

At Aprecia, we strive every day to imagine, inspire, and transform the new age of digital medicine.

Aprecia is a unique drug delivery technology platform company that’s committed to transforming the patient and caregiver experience by reducing pill burden or simply making medicines easier to take. We imagine a world where medications are no longer challenging for patients to take or for caregivers to give. And we inspire each other every day to seek innovative solutions that address administration and adherence needs.

Built upon our proprietary three-dimensional printing (3DP) technology platform, we focus on opportunities where there is a need for medicines that are easy to take. Aprecia is the first and only company in the world utilizing this cutting-edge 3DP technology platform to develop and manufacture pharmaceutical products on a commercial scale. We believe our platform will generate multiple product-enhancing drug delivery technologies that can be used across all therapeutic categories. Our first innovation that leverages 3DP is ZipDose® Technology and is uniquely able to accommodate a high dosage load (over 1000 mg of active pharmaceutical ingredient) in a rapidly orodispersible tablet with a wide range of taste masking capabilities. With these capabilities, ZipDose Technology is redefining the fast-melt market.

FEATURED PRODUCTS

ZipDose® Technology ZipDose® Technology

Developed with Aprecia’s proprietary 3DP manufacturing process, ZipDose® Technology helps patients who need medicines that are easy to take and caregivers—including physicians and nurse practitioners—who want medicines that are easy to administer. By enabling delivery of high-dose medications in a rapidly disintegrating form, ZipDose overcomes patient adherence and difficulty swallowing challenges.

CONTACT INFORMATION

Aprecia Pharmaceuticals

10901 Kenwood Rd

Blue Ash, OH 45242

UNITED STATES

Phone: (513) 984-5000

Contact: Don Wetherhold, SVP, Business Development

FEATURED ARTICLES